Terry F Casey, RPH | |
201 N Main St, Chamberlain, SD 57325-1240 | |
(605) 734-5871 | |
(605) 734-4245 |
Full Name | Terry F Casey |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 201 N Main St, Chamberlain, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659476117 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 3377 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Terry F Casey, RPH Po Box 549, Chamberlain, SD 57325-0549 Ph: (605) 234-6486 | Terry F Casey, RPH 201 N Main St, Chamberlain, SD 57325-1240 Ph: (605) 734-5871 |
News Archive
13 young adults with tetraplegia are able to feed themselves, hold a drink, brush their teeth, and write as a result of a novel surgical technique which connects functioning nerves with injured nerves to restore power in paralyzed muscles.
"Senate Finance Chairman Max Baucus, D-Mont., said Tuesday he expects Senate health-care legislation will include provisions encouraging doctors to compare drugs and therapies for their effectiveness," Dow Jones Newswires reports.
Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.
Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance, meaning systematic followup.
Genocea Biosciences, Inc., a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced positive top-line data from a Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes.
› Verified 3 days ago
Cassi Lynne Leiferman, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-7110 | |
Mr. James Loren Butler, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-734-5871 Fax: 605-734-4245 | |
Drew Ruhlman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-234-5871 | |
Timothy John Travis, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-234-5871 | |
Nicholas Elgersma, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-234-5871 | |
James D Bregel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-734-5871 |